Vascular and renal effects of vasopressin and its antagonists in conscious rats with chronic myocardial infarction; evidence for receptor shift

By Lankhuizen I.M.   van Veghel R.   Saxena P.R.   Schoemaker R.G.  

European Journal of Pharmacology, Vol. 423, Iss. 2, 2001-07 ,pp. : 195-202

Elsevier

Access to resources Recommend Favorite

Evidence that atypical vasopressin V 2 receptor in inner medulla of kidney is V 1B receptor

By Saito M.   Tahara A.   Sugimoto T.   Abe K.   Furuichi K.  

European Journal of Pharmacology, Vol. 401, Iss. 3, 2000-08 ,pp. : 289-296

Elsevier

Access to resources Recommend Favorite

Neuromodulation of memory in the hippocampus by vasopressin

By Alescio-Lautier B.   Paban V.   Soumireu-Mourat B.  

European Journal of Pharmacology, Vol. 405, Iss. 1, 2000-09 ,pp. : 63-72

Elsevier

Access to resources Recommend Favorite

Vasopressin in cardiovascular patients: therapeutic implications

By Zimmerman Michael A   Albright Tracy N   Raeburn Christopher D   Selzman Craig H  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 5, 2002-05 ,pp. : 505-512

Informa Healthcare

Access to resources Recommend Favorite

The therapeutic potential of vasopressin in cardiopulmonary resuscitation

By Salam Amar Mohammad  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 3, 2005-03 ,pp. : 517-520

Informa Healthcare

Access to resources Recommend Favorite